MDMA (ecstasy) produces a unique set of behavioral effects in rats that distinguishes it from both stimulants and hallucinogens. In a series of behavioral tests, the effects of MDMA at various doses were compared with those of methamphetamine (a stimulant) and DOI (a hallucinogen). The behavioral profiles allowed researchers to differentiate MDMA from these other drugs. Additionally, four structural analogues of MDMA were tested, but none exactly replicated MDMA's profile, some resembling the stimulant or hallucinogen instead. This highlights MDMA's distinct pharmacological identity as an entactogen.
The psychomotor stimulation and pro-social effects of MDMA (ecstasy) in rats are eliminated by aromatic bromination, a chemical modification that replaces a hydrogen atom on the aromatic ring with bromine. The brominated compound retains affinity for the serotonin transporter (SERT), indicating that binding to SERT alone is insufficient to produce these behavioral effects. The findings suggest that other mechanisms beyond SERT binding are necessary for MDMA's characteristic psychomotor and pro-social actions.